Poll of the Day: Biden’s Approval Rating on Pandemic Edges Higher
Just over half of Americans (51%) in a new Washington Post/ABC News survey said they approve of the way President Biden is handing the coronavirus...
Medicare Advantage Plans Sometimes Deny Medically Necessary Care: Report
Private Medicare Advantage insurance plans are growing rapidly in popularity and are expected to cover a majority of Medicare beneficiaries within...
White House Pushes Wider Use of Covid Treatment Paxlovid
The Biden administration has secured the purchase of 20 million doses of Paxlovid, a treatment for Covid-19, and plans to make the drug more available...
234,000 Covid Deaths Could Have Been Prevented: Analysis
A new analysis by the Kaiser Family Foundation estimates that since June 2021, when vaccines were widely available to American adults, about 234,000...
Many Cancer Patients on Medicare Skip Filling High-Priced Prescriptions: Study
High drug prices often lead Americans on Medicare to hold off on filling their prescriptions, even for threatening diseases such as cancer, a study in...
Biden Administration Extends Covid-19 Public Health Emergency
The Biden administration on Wednesday extended the Covid-19 public health emergency that had been due to expire on April 16. The 90-day extension...
New Coronavirus Czar: $10 Billion Is Just a ‘Down Payment’ for Pandemic Funding
Dr. Ashish Jha took over Monday as the White House coronavirus response coordinator, replacing Jeff Zients. Jha, appointed by President Biden last...
Covid Vaccinations Have Saved 2.2 Million US Lives: Report
As the U.S. closes in on 1 million deaths from Covid-19, a new analysis finds that the death toll would have been far higher in the absence of...
Covid Takes Another Bite Out of US Life Expectancy
Life expectancy in the U.S. dropped again in 2021, according to a new analysis that tallies the terrible toll Covid-19 continued to take last year...
Medicare Finalizes Plan to Limit Coverage of Controversial New Alzheimer’s Drug
Medicare on Thursday finalized a decision to severely limit coverage of a costly and controversial new Alzheimer’s drug, announcing that it would only...